Inhibrx Biosciences, Inc.INBXNASDAQ
Loading
Interest Expense Over TimeStrong
Percentile Rank67
3Y CAGR-8.9%
5Y CAGR+2.4%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
-8.9%/yr
vs +81.6%/yr prior
5Y CAGR
+2.4%/yr
Recent deceleration
Acceleration
-90.5pp
Decelerating
Percentile
P67
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $12.20M | -9.6% |
| 2024 | $13.49M | -57.6% |
| 2023 | $31.84M | +97.7% |
| 2022 | $16.11M | +208.8% |
| 2021 | $5.22M | -51.8% |
| 2020 | $10.82M | +89.1% |
| 2019 | $5.72M | +286.4% |
| 2018 | $1.48M | -30.4% |
| 2017 | $2.13M | - |
| 2016 | $0.00 | - |